Calcilytix Medical Director

Rare Disease / Clinical Research

Calcilytix Therapeutics, Inc., a BridgeBio company

QC-verified· March 2026 PI on 4 trials

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Autosomal dominant hypocalcemia

Clinical trials (4)

NCT05680818
NCT05227287
NCT04581629
NCT07080385

Verify independently

ClinicalTrials.gov PI search for Calcilytix Medical Director

Other specialists for Autosomal dominant hypocalcemia

Peers ranked by clinical-trial PI role, publications, and verification quality.

Agnes Linglart, MD, PhD
Assistance Publique - Hôpitaux de Paris
Saleh K Saleh, MD
Minia University
Minya Governorate
Anne Blanchard, MD, PhD
Assistance Publique - Hôpitaux de Paris
Karen K Winer, M.D., PT
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
OR
Lars Rejnmark, DmSci, PhD
Aarhus University Hospital

See all specialists for Autosomal dominant hypocalcemia →

← Back to specialists directory